Axonics receives FDA approval for 3T full-body MRI scans
Axonics, a company that has developed and is commercialising novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, has...
FDA approves Percept PC neurostimulator with BrainSense technology
Medtronic has announced it received US Food and Drug Administration (FDA) approval for the Percept PC deep brain stimulation (DBS) system. BrainSense technology makes...
Mainstay Medical announces FDA approval of ReActiv8 neurostimulation system for chronic low back pain
Mainstay Medical has announced that the US Food and Drug Administration (FDA) has approved the company’s premarket approval (PMA) application for ReActiv8, its implantable...
FDA approval for Axonics’ wireless patient Remote Control with SmartMRI technology
Axonics, a company that has developed implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, has announced US Food and...
